Healthcare Realty's Second Act: Outperforming Its Own Blueprint and Scaling a New MOB Model
A year into its strategic plan, HR is beating every target, raising guidance again, and finally putting capital to work — including a growing KKR JV pipeline.
HR · Earnings Call · 2026-07-31
A Year In, Outperforming the Blueprint
When Healthcare Realty unveiled its strategic plan a year ago, it promised clarity, purpose, and a path to reestablish credibility. Today, President & CEO Peter A. Scott reports the company is doing exactly that — and then some. “outperforming every 1 of our key objectives over the last 4 quarters” — Peter A. Scott, President and Chief Executive Officer · 2026-07-31 — from same-store NOI growth averaging 5.7% to occupancy creeping toward 93% and retention near 90%. The medical office operator has raised guidance every quarter since, including another $0.02 this quarter, driven by strong operations, a successful convertible bond offering, and accretive capital allocation. This is a story of execution, not just aspiration. “Year to date, we have executed 3.5 million square feet of leases” — Peter A. Scott, President and Chief Executive Officer · 2026-07-31 — over 10% of the portfolio — and the weighted average remaining lease term has improved by 15 months since the plan was disclosed. The company attributes much of this to a new leasing model designed to drive ROI, with lease IRRs up nearly 3,000 basis points and payback periods down 25%.Health Systems: Friend, Tenant, and Buyer
A core facet of the strategic plan was deepening relationships with health systems, and the results are tangible. In late June, HR executed ~160k sq ft of renewals with CommonSpirit across five states at a positive 7% cash leasing spread, and simultaneously sold CommonSpirit 15 acres in Denver for $16M while retaining future MOB development rights. A similar win-win came with Wellstar, where HR sold the Kennestone Cancer Center for $36M (over $600/sq ft, mid-5% cap) and recycled proceeds into JV acquisitions. Then came Ascension St. Thomas in Nashville, an LOI for 203k sq ft at an 11% cash leasing spread, coupled with a $35M HR investment in its MOBs while the hospital undergoes a $120M modernization. These aren't just leases; they're a template for health system relationships that create mutual value. As Scott puts it, “Our dialogue with health systems has increased exponentially over the last year” — Peter A. Scott, President and Chief Executive Officer · 2026-07-31 — and materially sewn into the portfolio's future growth.Capital Allocation: The Engine Twice Over
The balance sheet is now a weapon. In Q2, HR raised $1.1B via a $700M exchangeable note (coupon 3%) and a $400M delayed draw term loan, addressing maturities through 2027 and locking in ~100bps of savings relative to original guidance. The exchangeable notes were effectively priced 40% above the stock — a strong vote of confidence. Meanwhile, the KKR joint venture is accelerating. Since March, HR has closed or has under contract/LOI ~$200M of assets (or $40M at HR's share) with going-in cash yields to HR of ~7.5%, highly accretive to its ~6% implied cap rate. These JV acquisitions span Greenwich, Charleston, Port St. Lucie, Seattle, and Denver. The company also repurchased $75M of stock in Q2 and maintains a disciplined stance — including the willingness to sell core assets when pricing makes sense. The balance sheet repair shows up in the fundamentals: Liabilities to assets have declined as proceeds from dispositions have been used to pay down debt and fund growth.The Re-rating Equation
HR's stock has already responded, up ~10% over the last 90 days, but the full-history chart still shows a deep drawdown from 2020. Scott acknowledges the valuation is improving but is plainly not satisfied:The market's skepticism about a medical office REIT's growth potential is what HR sees as opportunity. In prior quarters, the tone was more cautious — as Scott said in February, “We are carefully using the O word within the office here at the moment.” — Peter A. Scott, Chief Executive Officer (CEO) · 2026-02-13 Now, with a year of proof under its belt, the language has shifted. As he noted in May, “we're tracking ahead of schedule at this point in time.” — Peter Scott, Chief Executive Officer · 2026-05-01 That schedule now includes scaling the platform with JV capital, redevelopment yields in the 9-12% range, and an ambition to be the defining player in outpatient medical. The question is whether the market will reward consistent execution with a multiple that reflects the new reality. HR is betting that, one year in, it's no longer just a promise — it's a pattern.We are not satisfied. And we are not slowing down.